| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AJS-2 Bispecific and CAR T-cell immunotherapies for advanced prostate cancer
|
Hawley, Jessica E.
|
|
|
34 |
S3 |
p. S1349
|
artikel
|
| 2 |
AJS-4 Current status and future challenges in clinical development of CAR-T cell therapy and bispecific antibody therapy for solid tumors
|
Kitano, Shigehisa
|
|
|
34 |
S3 |
p. S1349
|
artikel
|
| 3 |
AJS-1 Navigating the expanding treatment landscape in R/R diffuse large B-cell lymphoma – how to incorporate CAR T-cell therapy and bispecific antibodies
|
Nastoupil, Loretta J.
|
|
|
34 |
S3 |
p. S1349
|
artikel
|
| 4 |
Disclaimer
|
|
|
|
34 |
S3 |
p. iii
|
artikel
|
| 5 |
DJS-1 Regulatory challenges in the Asian clinical TriaLs network for cAancerS (ATLAS) project
|
Nakamura, Kenichi
|
|
|
34 |
S3 |
p. S1350
|
artikel
|
| 6 |
DJS-4 Utilization of clinical research data other than conventional clinical trials for pharmaceuticals and medical devices
|
Yamamoto, Haruko
|
|
|
34 |
S3 |
p. S1350
|
artikel
|
| 7 |
EC-3 Development of oncology fellowship between KSMO and KCSG in Korea: Current status of oncology education and framework for future oncology of KSMO
|
Park, Yeon Hee
|
|
|
34 |
S3 |
p. S1375
|
artikel
|
| 8 |
EC-6 Educational initiative at Japanese Society of Medical Oncology (JSMO)
|
Kinoshita, Ichiro
|
|
|
34 |
S3 |
p. S1375-S1376
|
artikel
|
| 9 |
EC-2 Oncology education initiatives at Chinese Society of Clinical Oncology (CSCO)
|
Zhong, Jia
|
|
|
34 |
S3 |
p. S1375
|
artikel
|
| 10 |
EC-4 Oncology education initiatives at Singapore Society of Oncology (SSO)
|
Ling Poon, Eileen Yi
|
|
|
34 |
S3 |
p. S1375
|
artikel
|
| 11 |
EC-5 Oncology education initiatives at Taiwan Oncology Society (TOS)
|
Hsu, Chiun
|
|
|
34 |
S3 |
p. S1375
|
artikel
|
| 12 |
Editorial Board
|
|
|
|
34 |
S3 |
p. i
|
artikel
|
| 13 |
EJS-4 Development of molecularly-stratified precision medicine in lung cancer
|
Matsumoto, Shingo
|
|
|
34 |
S3 |
p. S1351
|
artikel
|
| 14 |
EL06 Supportive care in cancer and adverse event management
|
Naito, Tateaki
|
|
|
34 |
S3 |
p. S1374
|
artikel
|
| 15 |
GL04-3 Evidence for cancer vaccine therapy and immuno-cell therapy
|
Shimoi, Tatsunori
|
|
|
34 |
S3 |
p. S1376
|
artikel
|
| 16 |
GL03-3 Venous thromboembolism in the era of oncocardiology
|
Maruyama, Dai
|
|
|
34 |
S3 |
p. S1376
|
artikel
|
| 17 |
JS01-1 Aggregating comprehensive cancer genomic data and clinical information into C-CAT for utilization
|
Ohkuma, Yusuke
|
|
|
34 |
S3 |
p. S1353
|
artikel
|
| 18 |
JS04-1 Clinical practice guidelines in cardio-oncology and the definition of cancer therapy-related cardiovascular toxicity
|
Sase, Kazuhiro
|
|
|
34 |
S3 |
p. S1354
|
artikel
|
| 19 |
JS01-6 Imagine all the patients living life without recurrence
|
Oki, Eiji
|
|
|
34 |
S3 |
p. S1353-S1354
|
artikel
|
| 20 |
JS01-4 Liquid biopsy-guided precision oncology in advanced solid tumors
|
Nakamura, Yoshiaki
|
|
|
34 |
S3 |
p. S1353
|
artikel
|
| 21 |
JS01-3 Optimizing cancer genome medicine in clinical practice in Japan
|
Muto, Manabu
|
|
|
34 |
S3 |
p. S1353
|
artikel
|
| 22 |
JS01-2 Toward efficient operation of expert panels
|
Komine, Keigo
|
|
|
34 |
S3 |
p. S1353
|
artikel
|
| 23 |
JS01-5 Whole genome sequencing-based precision cancer medicine in Japan
|
Kohno, Takashi
|
|
|
34 |
S3 |
p. S1353
|
artikel
|
| 24 |
ME05 Evolving landscape of systemic therapy for advanced hepatocellular carcinoma
|
Kelley, Robin Kate
|
|
|
34 |
S3 |
p. S1377
|
artikel
|
| 25 |
ME13 Existing controvercies in bladder and kidney cancer
|
Powles, Thomas
|
|
|
34 |
S3 |
p. S1378
|
artikel
|
| 26 |
ME11 How to overcome and circumvent acquired resistance to osimertinib or lazertinib in advanced EGFR mutant lung cancer?
|
Cho, Byoung Chul
|
|
|
34 |
S3 |
p. S1378
|
artikel
|
| 27 |
ME10 Impact of the NETSARC network of reference centers for the diagnosis and treatment of sarcomas in France since 2010
|
Blay, Jean-Yves
|
|
|
34 |
S3 |
p. S1377-S1378
|
artikel
|
| 28 |
ME07 Management of women with advanced and recurrent gynecologic malignancies
|
Tewari, Krishnansu Sujata
|
|
|
34 |
S3 |
p. S1377
|
artikel
|
| 29 |
ME01 New developments in B cell lymphoma
|
Leonard, John P.
|
|
|
34 |
S3 |
p. S1377
|
artikel
|
| 30 |
ME04 Novel immunotherapy combinational approach in advanced oesophago-gastric adenocarcinoma
|
Chau, Ian
|
|
|
34 |
S3 |
p. S1377
|
artikel
|
| 31 |
MO7-1 A Bayesian network meta-analysis comparing biliary stent types’ outcomes in unresectable malignant biliary obstruction
|
Aryanti, Citra
|
|
|
34 |
S3 |
p. S1399
|
artikel
|
| 32 |
MO58-5 Abemaciclib-induced liver dysfunction in metastatic breast cancer
|
Miyaki, Toshiko
|
|
|
34 |
S3 |
p. S1433
|
artikel
|
| 33 |
MO68-4 A chemoproteoinformatics approach demonstrates that aspirin increases sensitivity to MEK inhibition by directly binding to RPS5
|
Boku, Shogen
|
|
|
34 |
S3 |
p. S1438
|
artikel
|
| 34 |
MO34-4 Advanced hepatocellular carcinoma viral status and immunotherapy efficacy: A propensity-score matched analysis
|
Low, Qin Jian
|
|
|
34 |
S3 |
p. S1417-S1418
|
artikel
|
| 35 |
MO4-4 Affecting burden and cost of care in caregiver of dependent advanced stage of cancer patients
|
Chansriwong, Phichai
|
|
|
34 |
S3 |
p. S1397-S1398
|
artikel
|
| 36 |
MO15-6 A highly efficient procedure for the recovery of DNA from formalin-fixed paraffin-embedded tissue sections
|
Oba, Utako
|
|
|
34 |
S3 |
p. S1406
|
artikel
|
| 37 |
MO2-7 A multicenter prospective observational study of pre-existing autoantibodies in patients with small-cell lung cancer treated with ICI
|
Hata, Akito
|
|
|
34 |
S3 |
p. S1396
|
artikel
|
| 38 |
MO39-5 Analysis of perioperative chemotherapy-mediated genomic changes in gastric cancer
|
Ikegame, Ko
|
|
|
34 |
S3 |
p. S1421-S1422
|
artikel
|
| 39 |
MO42-6 Analysis of sperm preservation in patients with mediastinal germ cell tumor patients
|
Umamoto, Kotaro
|
|
|
34 |
S3 |
p. S1423-S1424
|
artikel
|
| 40 |
MO57-1 A phase II study of chemotherapy plus local therapy for non-small cell lung cancer with oligometastases: TORG1529
|
Saito, Go
|
|
|
34 |
S3 |
p. S1431-S1432
|
artikel
|
| 41 |
MO31-5 A project to investigate the actual status of biomarker testing in unresectable advanced or recurrent non-small cell lung cancer: WJOG15421 L (REVEAL)
|
Kawashima, Yosuke
|
|
|
34 |
S3 |
p. S1416
|
artikel
|
| 42 |
MO46-1 A retrospective study on the development of osteonecrosis of the jaws (ONJ) in patients treated with bone modifying agents (BMA)
|
Yamanaka, Taro
|
|
|
34 |
S3 |
p. S1425
|
artikel
|
| 43 |
MO54-5 Assessment of the impact of COVID-19 on malignancy surgeries by interrupted time series analysis using real world data
|
Nio, Mariko
|
|
|
34 |
S3 |
p. S1430
|
artikel
|
| 44 |
MO31-3 Association between tumor mutation burden and oncogenic mutation affecting the immune system of patients with non-small cell lung cancer
|
Kobayashi, Takayuki
|
|
|
34 |
S3 |
p. S1416
|
artikel
|
| 45 |
MO57-4 Association of Glasgow prognostic score with efficacy and safety of first-line osimertinib in EGFR mutated NSCLC (OSI-FACT exploratory analysis)
|
Oya, Yuko
|
|
|
34 |
S3 |
p. S1432
|
artikel
|
| 46 |
MO58-3 A study of palbociclib-resistant cases at our hospital-discussion on abemaciclib treatment feasibility
|
Noguchi, Eiichiro
|
|
|
34 |
S3 |
p. S1433
|
artikel
|
| 47 |
MO34-3 A systematic review of the effect of statin use on risk of hepatocellular carcinoma
|
Mandaring, Putri Patricia
|
|
|
34 |
S3 |
p. S1417
|
artikel
|
| 48 |
MO39-1 CapeOX therapy for elderly pts with advanced gastric cancer (phase II study with geriatric assessment, TCOG GI-1601)
|
Muto, Osamu
|
|
|
34 |
S3 |
p. S1421
|
artikel
|
| 49 |
MO71-8 Carboplatin-based vs. cisplatin-based therapy for cervical cancer survival: A systematic review
|
Kumar, Chandni
|
|
|
34 |
S3 |
p. S1440
|
artikel
|
| 50 |
MO58-4 CDK4/6 inhibitors as maintenance therapy after initial chemotherapy: A retrospective single-institute study
|
Fujisawa, Fumie
|
|
|
34 |
S3 |
p. S1433
|
artikel
|
| 51 |
MO15-4 Challenges for lung cancer screening using blood samples – methylome analysis of plasma-derived cell-free DNA
|
Nakagomi, Takahiro
|
|
|
34 |
S3 |
p. S1405
|
artikel
|
| 52 |
MO11-6 Characteristics of patients with pneumocystis pneumonia during cancer chemotherapy enrolled in the institutional serious adverse event database
|
Tsujimura, Hideki
|
|
|
34 |
S3 |
p. S1403
|
artikel
|
| 53 |
MO13-4 Characterization of URST7 as a potential biomarker and therapeutic target for oral cancer
|
Tsevegjav, Bayarbat
|
|
|
34 |
S3 |
p. S1404
|
artikel
|
| 54 |
MO72-5 Chemotherapy at home: Efficiency of anticipated treatment preparation
|
Touil, Yacine
|
|
|
34 |
S3 |
p. S1441
|
artikel
|
| 55 |
MO21-5 Chemotherapy regimen of Kaposi sarcoma in HIV/AIDS patients: A systematic review of randomized controlled trials
|
Kurniawan, Andree
|
|
|
34 |
S3 |
p. S1410
|
artikel
|
| 56 |
MO23-5 Choroid plexus tumors: A rare but formidable neurological malignancy
|
Manjunath, Niveditha
|
|
|
34 |
S3 |
p. S1411
|
artikel
|
| 57 |
MO41-2 Circulating tumor DNA (ctDNA) predicts prognosis in triple-negative breast cancer patients: A systematic review
|
Lokanata, Edellin F.
|
|
|
34 |
S3 |
p. S1422-S1423
|
artikel
|
| 58 |
MO48-2 Clinical adaptability of HSP90 inhibitor in refractory AML based on genetic mutation
|
Ogata, Hiraku
|
|
|
34 |
S3 |
p. S1425
|
artikel
|
| 59 |
MO7-5 Clinical and genomic features of MSI-H and TMB-high pancreatic cancer: A real world data from the C-CAT database
|
Sakakida, Tomoki
|
|
|
34 |
S3 |
p. S1400
|
artikel
|
| 60 |
MO6-1 Clinical characteristics and diagnostic process of NAFLD-associated HCC
|
Ueno, Masayuki
|
|
|
34 |
S3 |
p. S1398
|
artikel
|
| 61 |
MO9-1 Clinical characteristics of HER2-low stage I triple-negative breast cancer
|
Sanomachi, Tomomi
|
|
|
34 |
S3 |
p. S1401
|
artikel
|
| 62 |
MO10-2 Clinical decisions by the Molecular Tumor Board on comprehensive genomic profiling tests in Japan: A retrospective observational study
|
Shirota, Hidekazu
|
|
|
34 |
S3 |
p. S1402
|
artikel
|
| 63 |
MO36-3 Clinical management of cancer of unknown primary with unfavorable subset: A retrospective analysis
|
Tono, Yasutaka
|
|
|
34 |
S3 |
p. S1419
|
artikel
|
| 64 |
MO69-4 Clinical outcomes of everolimus for patients with advanced neuroendocrine tumors arising from the rectum: A single-institutional retrospective study
|
Kim, Yuntae
|
|
|
34 |
S3 |
p. S1438
|
artikel
|
| 65 |
MO25-2 Clinical outcomes of systemic therapy for metastatic renal cell carcinoma patients on hemodialysis
|
Iwasa, Shun
|
|
|
34 |
S3 |
p. S1412
|
artikel
|
| 66 |
MO25-4 Clinical outocomes of nivolumab plus ipilimumab in metastatic renal cell carinoma
|
Kato, Taigo
|
|
|
34 |
S3 |
p. S1412
|
artikel
|
| 67 |
MO42-4 Clinical picture of thyroid cancer from the view of time to death from diagnosis
|
Ito, Tokiko
|
|
|
34 |
S3 |
p. S1423
|
artikel
|
| 68 |
MO16-3 Clinical relevance of comprehensive genome profiling using real-world data in colorectal cancer
|
Okugawa, Yoshinaga
|
|
|
34 |
S3 |
p. S1406
|
artikel
|
| 69 |
MO41-3 Clinical significance of oncogenic miRNAs (21,17,10a &10b) expression with breast cancer stem cells in breast carcinoma
|
Dwivedi, Shailendra
|
|
|
34 |
S3 |
p. S1423
|
artikel
|
| 70 |
MO60-3 Clinical utility of gBRCA testing (BRACAnalysis) for patients with unresectable pancreatic cancer
|
Kawamoto, Yasuharu
|
|
|
34 |
S3 |
p. S1434
|
artikel
|
| 71 |
MO49-2 CNS prophylaxis in diffuse large B-cell lymphoma: A meta-analysis and systematic review
|
Arnejo Sy, Florge Francis
|
|
|
34 |
S3 |
p. S1426
|
artikel
|
| 72 |
MO9-4 Cognitive decline after receiving endocrine therapy and/or chemotherapy in breast cancer patients: A systematic review
|
Tancherla, Angeline
|
|
|
34 |
S3 |
p. S1401-S1402
|
artikel
|
| 73 |
MO8-6 Comparision of the expression of p53 and survivin in fibroadenoma and invasive ductal carcinoma of the breast
|
Banoria, Neeraj Kumar
|
|
|
34 |
S3 |
p. S1401
|
artikel
|
| 74 |
MO35-3 Comparison of clinical outcomes between 1st-line osimertinib, 1G/2G EGFR-TKIs followed by osimertinib and without osimertinib
|
Uehara, Yuji
|
|
|
34 |
S3 |
p. S1418
|
artikel
|
| 75 |
MO5-5 Comparison of first-line therapy regimens for non-small cell lung cancer with different Japanese real world data sources
|
Nio, Mariko
|
|
|
34 |
S3 |
p. S1398
|
artikel
|
| 76 |
MO57-6 Comprehensive genomic profiling is effective in determining treatment decisions for advanced solid tumors patients
|
Ishida, Masaki
|
|
|
34 |
S3 |
p. S1432
|
artikel
|
| 77 |
MO69-5 Contribution of neuroendocrine differentiation to prognosis in extrapulmonary small cell or neuroendocrine carcinoma
|
Takahashi, Nobuyuki
|
|
|
34 |
S3 |
p. S1438-S1439
|
artikel
|
| 78 |
MO13-2 Covalent FGFR inhibitor futibatinib exhibits sustained antitumor effects compared with ATP-competitive inhibitors
|
Muraoka, Hiromi
|
|
|
34 |
S3 |
p. S1404
|
artikel
|
| 79 |
MO14-6 CT-based AI machine learning model for predicting efficacy of chemoradiotherapy for esophageal squamous cell carcinoma
|
Kasai, Akinari
|
|
|
34 |
S3 |
p. S1405
|
artikel
|
| 80 |
MO72-1 Current status and problems of comprehensive cancer genome profiling test in biliary tract and pancreatic cancer in our institutions
|
Okuyama, Hiroyuki
|
|
|
34 |
S3 |
p. S1441
|
artikel
|
| 81 |
MO40-4 DCF regimen might be useful as neo-adjuvant chemotherapy for esophageal cancer from our institutional experience
|
Kobayashi, Kazuma
|
|
|
34 |
S3 |
p. S1422
|
artikel
|
| 82 |
MO15-3 Deep target sequencing of cytological tumor cells using whole genome amplification
|
Amemiya, Kenji
|
|
|
34 |
S3 |
p. S1405
|
artikel
|
| 83 |
MO19-1 Definitive chemoradiation therapy with docetaxel, nedaplatin, and 5-fluorouracil (DNF-R) for locally advanced esophageal cancer – long-term follow-up
|
Ohnuma, Hiroyuki
|
|
|
34 |
S3 |
p. S1407-S1408
|
artikel
|
| 84 |
MO7-6 Differences between tissue and blood specimens in CGP of pancreatic cancer from a real-world data of C-CAT
|
Doi, Toshifumi
|
|
|
34 |
S3 |
p. S1400
|
artikel
|
| 85 |
MO58-2 Differences in treatment response to CDK4/6 inhibitors and endocrine therapy between HER2-negative and HER2-low expression groups
|
Omori, Reo
|
|
|
34 |
S3 |
p. S1432-S1433
|
artikel
|
| 86 |
MO40-5 Early administration of pegfilgrastim contributes to the safety of DCF therapy as neoadjuvant chemotherapy for esophageal cancer
|
Morita, Ryuichi
|
|
|
34 |
S3 |
p. S1422
|
artikel
|
| 87 |
MO2-5 Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancer
|
Takeuchi, Eiji
|
|
|
34 |
S3 |
p. S1395-S1396
|
artikel
|
| 88 |
MO28-5 Effectiveness of ketamine for depression among advanced cancer patients in palliative care: A systematic review
|
Cipta, Darien Alfa
|
|
|
34 |
S3 |
p. S1414
|
artikel
|
| 89 |
MO61-3 Effect of cancer cachexia on the outcomes of first-line chemotherapy in pancreatic cancer: A claims database study
|
Furuse, Junji
|
|
|
34 |
S3 |
p. S1435
|
artikel
|
| 90 |
MO18-2 Effects and risk factors of TAS-102 in real-world patients with metastatic colorectal cancer, EROTAS-R study
|
Yoshida, Naohisa
|
|
|
34 |
S3 |
p. S1407
|
artikel
|
| 91 |
MO48-4 Efficacy and quality of life in blinatumomab treatment in patients with acute lymphoblastic leukemia: Systematic review
|
Herijanto, Billie Edgara
|
|
|
34 |
S3 |
p. S1425
|
artikel
|
| 92 |
MO21-6 Efficacy and safety of chemotherapy in metastatic malignant phyllodes tumors
|
Takigawa, Aya
|
|
|
34 |
S3 |
p. S1410-S1411
|
artikel
|
| 93 |
MO50-4 Efficacy and safety of commercially approved BCMA-targeting CAR-T therapy in triple-class refractory multiple myeloma
|
Nishimura, Noriko
|
|
|
34 |
S3 |
p. S1427-S1428
|
artikel
|
| 94 |
MO46-2 Efficacy and safety of palliative radiation therapy for tumor bleeding in patients with advanced pancreatic cancer
|
Shibuki, Taro
|
|
|
34 |
S3 |
p. S1425
|
artikel
|
| 95 |
MO59-2 Efficacy and safety of pembrolizumab plus chemotherapy in patient with metastatic TNBC: A systematic review
|
Sabran, Mohammad Zuhriansyah
|
|
|
34 |
S3 |
p. S1434
|
artikel
|
| 96 |
MO49-5 Efficacy and safety of R-THP-COP therapy for elderly patients with untreated diffuse large B-cell lymphoma
|
Kato, Daishi
|
|
|
34 |
S3 |
p. S1427
|
artikel
|
| 97 |
MO39-4 Efficacy and safety of trifluridine/tipiracil as a salvage-line treatment for patients with advanced gastric cancer
|
Fukuda, Koshiro
|
|
|
34 |
S3 |
p. S1421
|
artikel
|
| 98 |
MO1-4 Efficacy of immune checkpoint inhibitors plus chemotherapy for TTF-1-negative non-squamous non-small cell lung cancer
|
Iso, Hirokazu
|
|
|
34 |
S3 |
p. S1394
|
artikel
|
| 99 |
MO61-6 Efficacy of third-line chemotherapy after liposomal irinotecan and fluorouracil with folinic acid for pancreatic cancer
|
Kawasaki, Reina
|
|
|
34 |
S3 |
p. S1435
|
artikel
|
| 100 |
MO56-2 Efficacy of whole brain radiotherapy for patients with leptomeningeal metastasis of non-small cell lung cancer: NEJ049
|
Furuta, Megumi
|
|
|
34 |
S3 |
p. S1431
|
artikel
|
| 101 |
MO38-3 EGFR activation elicited adaptive resistance to lorlatinib in ALK-rearranged non-small cell lung cancer cells
|
Katayama, Yuki
|
|
|
34 |
S3 |
p. S1421
|
artikel
|
| 102 |
MO52-6 Estimating suicide incidence over time in cancer patients in the early period following cancer diagnosis
|
Watanabe, Kaname
|
|
|
34 |
S3 |
p. S1429
|
artikel
|
| 103 |
MO58-6 Evaluation of cardiotoxicity by anti-HER2 therapy
|
Itagaki, Tomoko
|
|
|
34 |
S3 |
p. S1433-S1434
|
artikel
|
| 104 |
MO62-4 Evaluation of the significance of subcarinal lymph node dissection in stage IB non-small cell lung cancer
|
Wang, Feng
|
|
|
34 |
S3 |
p. S1435-S1436
|
artikel
|
| 105 |
MO52-4 Examination of patient characteristics in breast cancer patients who underwent BRCA genetic testing, according to reason for taking the test
|
Sakakibara, Ayaka
|
|
|
34 |
S3 |
p. S1428-S1429
|
artikel
|
| 106 |
MO71-7 Extensive analysis of machine learning algorithms in predicting the treatment outcome of HIFU ablation of adenomyosis
|
Akpinar, Emine
|
|
|
34 |
S3 |
p. S1440
|
artikel
|
| 107 |
MO36-6 Factors related to family caregiver-perceived burden associated with testing and diagnosis of cancer of unknown primary
|
Ishida, Kyoko
|
|
|
34 |
S3 |
p. S1420
|
artikel
|
| 108 |
MO28-6 Feasibility of the online-based QOL survey in patients with head and neck cancer. A multi-center, prospective study
|
Ishiki, Hiroto
|
|
|
34 |
S3 |
p. S1414
|
artikel
|
| 109 |
MO20-5 Five-year survival rate of AYA patients from sarcoma: A prospective fixed cohort study in Bangladesh
|
Al Mamun Khan, Abdullah
|
|
|
34 |
S3 |
p. S1409
|
artikel
|
| 110 |
MO12-2 G-CVP therapy using obinutuzumab for follicular lymphoma
|
Yamada, Toshiki
|
|
|
34 |
S3 |
p. S1404
|
artikel
|
| 111 |
MO10-5 Germline and somatic whole exome sequencing identifies a novel candidate gene in double primary BCRA-associated cancers
|
Tanioka, Maki
|
|
|
34 |
S3 |
p. S1402-S1403
|
artikel
|
| 112 |
MO29-2 Health literacy in adolescents and young adult oncology: A review on measurement tools
|
Tian Woon, Brian Shao
|
|
|
34 |
S3 |
p. S1415
|
artikel
|
| 113 |
MO72-6 Health-related quality of life in different states of Thai patients with breast cancer – preliminary report
|
Luangdilok, Sutima
|
|
|
34 |
S3 |
p. S1441-S1442
|
artikel
|
| 114 |
MO21-2 High incidence of cancer therapeutics-related cardiac dysfunction in the patients with cardiac sarcoma
|
Uehara, Koki
|
|
|
34 |
S3 |
p. S1410
|
artikel
|
| 115 |
MO65-2 High intramuscular adipose tissue content is a favorable prognostic factor in patients with advanced gastric cancer treated with nivolumab
|
Tanaka, Toshimitsu
|
|
|
34 |
S3 |
p. S1436
|
artikel
|
| 116 |
MO16-5 Identification and evaluation of a serum microRNA panel for screening advanced colorectal polyps
|
Ng, Lui
|
|
|
34 |
S3 |
p. S1406
|
artikel
|
| 117 |
MO13-5 Identification of URST1 as a biomarker and therapeutic target for lung cancer
|
Takano, Atsushi
|
|
|
34 |
S3 |
p. S1405
|
artikel
|
| 118 |
MO7-4 Impact of biliary drainage for pancreatic cancer treated with nanoliposomal irinotecan, fluorouracil and folinic acid
|
Nishikawa, Kazuo
|
|
|
34 |
S3 |
p. S1400
|
artikel
|
| 119 |
MO51-2 Impact of COVID-19 on cancer care in India: A multi-institutional experience
|
Behera, Manoj Kumar
|
|
|
34 |
S3 |
p. S1428
|
artikel
|
| 120 |
MO51-6 Impact of COVID-19 pandemic on the diagnosis of cancers – a systematic review
|
Tik, Cheung Ka
|
|
|
34 |
S3 |
p. S1428
|
artikel
|
| 121 |
MO19-4 Impact of tislelizumab on health-related quality of life in Asian patients with esophageal squamous cell carcinoma
|
Kato, Ken
|
|
|
34 |
S3 |
p. S1408
|
artikel
|
| 122 |
MO55-5 Impact of tumor genomic alterations on development of cancer cachexia in patients with advanced non-small cell lung cancer
|
Fujii, Hiroyuki
|
|
|
34 |
S3 |
p. S1430
|
artikel
|
| 123 |
MO56-3 Incidence of synchronous or metachronous multiple cancers and their predictive factors in patients with non-small cell lung cancer
|
Honda, Takeshi
|
|
|
34 |
S3 |
p. S1431
|
artikel
|
| 124 |
MO3-2 Influence of durvalumab consolidation on pneumonitis after chemoradiotherapy for unresectable non-small cell lung cancer
|
Murata, Saori
|
|
|
34 |
S3 |
p. S1396
|
artikel
|
| 125 |
MO45-4 Integrated learning of palliative care and oncology is useful for nursing patients with intractable cancer
|
Nakamura, Masako
|
|
|
34 |
S3 |
p. S1424-S1425
|
artikel
|
| 126 |
MO59-6 Karyopherin alpha 2 (KPNA2) predicts prognosis in breast cancer patients: A systematic review and meta-analysis
|
Lokanata, Michael G.
|
|
|
34 |
S3 |
p. S1434
|
artikel
|
| 127 |
MO54-1 Kynurenine-to-tryptophan ratio in solid cancer patients receiving ChAdOx1-nCoV-19 vaccine
|
Panasawatwong, Bunnatut
|
|
|
34 |
S3 |
p. S1429-S1430
|
artikel
|
| 128 |
MO1-1 LIGHT-NING 2nd interim analysis: Early safety of 1L nivolumab + ipilimumab +/- chemotherapy for NSCLC in Japan
|
Azuma, Koichi
|
|
|
34 |
S3 |
p. S1393
|
artikel
|
| 129 |
MO29-5 Location of death of adolescents and young adults with cancer
|
Yamada, Yoko
|
|
|
34 |
S3 |
p. S1415
|
artikel
|
| 130 |
MO35-5 Long-term efficacy and safety from the CROWN study in Japanese patients with ALK+ advanced non-small cell lung cancer
|
Teraoka, Shunsuke
|
|
|
34 |
S3 |
p. S1418
|
artikel
|
| 131 |
MO32-5 Metabolic interaction between gut microbiome and PIK3CA-mutated colorectal cancer: SCRUM-Japan MONSTAR-SCREEN
|
Boku, Shogen
|
|
|
34 |
S3 |
p. S1416
|
artikel
|
| 132 |
MO21-1 MRI radiomics to predict recurrence and prognosis in patients with soft-tissue sarcoma
|
Cheung, Eva Y.W.
|
|
|
34 |
S3 |
p. S1409
|
artikel
|
| 133 |
MO2-4 Multicenter pharmacokinetic study of pembrolizumab for non-small cell lung cancer in older adults aged over 75 years
|
Saeki, Sho
|
|
|
34 |
S3 |
p. S1395
|
artikel
|
| 134 |
MO66-6 Multicenter prospective observational study on treatment and prognosis of patients with primary small bowel cancer
|
Yamashita, Haruhiro
|
|
|
34 |
S3 |
p. S1437
|
artikel
|
| 135 |
MO17-2 Multicenter retrospective study of vulnerable patients with metastatic colorectal cancer: Results of second-line therapy
|
Kawakami, Kentaro
|
|
|
34 |
S3 |
p. S1406-S1407
|
artikel
|
| 136 |
MO57-5 Multicenter retrospective study to evaluate necitumumab plus CDDP/GEM after ICIs in advanced squamous-cell lung cancer in Japan (NINJA study)
|
Tanzawa, Shigeru
|
|
|
34 |
S3 |
p. S1432
|
artikel
|
| 137 |
MO20-6 Multidisciplinary treatment for retrospective sarcoma in Japan
|
Iwata, Shintaro
|
|
|
34 |
S3 |
p. S1409
|
artikel
|
| 138 |
MO26-1 Needs for cancer information in patients with rare cancers: Analysis of the questionnaire from the participants in “Meet the Expert on Rare Cancer”
|
Katoh, Yoko
|
|
|
34 |
S3 |
p. S1413
|
artikel
|
| 139 |
MO7-3 Network meta-analysis of first-line therapy for unresectable, advanced or recurrent biliary tract cancer
|
Kikuchi, Yoshinori
|
|
|
34 |
S3 |
p. S1399
|
artikel
|
| 140 |
MO63-3 Nivolumab monotherapy in second- or later-line treatment for advanced or recurrent esophageal cancer
|
Miyajima, Saori
|
|
|
34 |
S3 |
p. S1436
|
artikel
|
| 141 |
MO36-5 Non-familial prospective risk factors in predicting cancer of unknown primary: A systematic review and meta-analysis
|
Sembiring, Stephani Clarissa
|
|
|
34 |
S3 |
p. S1420
|
artikel
|
| 142 |
MO49-4 Obinutuzumab and reduced bendamustine for elderly follicular lymphoma patients: A single institution retrospective study
|
Masamoto, Yosuke
|
|
|
34 |
S3 |
p. S1426-S1427
|
artikel
|
| 143 |
MO5-4 Off-label or unapproved drug use and physicians' expectations of life insurance companies
|
Higuchi, Yukiko
|
|
|
34 |
S3 |
p. S1398
|
artikel
|
| 144 |
MO24-6 Olfactory system of canines to identify prostate cancer by urine-based detection: A systematic review and meta-analysis
|
Firsty, Naufal Nandita
|
|
|
34 |
S3 |
p. S1412
|
artikel
|
| 145 |
MO72-2 Oncofix – an oncology software prepared by Oncologist
|
Pathak, Abhishek
|
|
|
34 |
S3 |
p. S1441
|
artikel
|
| 146 |
MO44-4 Outcome for recurrent nasopharyngeal carcinoma in Malaysia: University Malaya Medical Centre, 2010-2019
|
Abdul Satar, Nur Fadhlina
|
|
|
34 |
S3 |
p. S1424
|
artikel
|
| 147 |
MO20-3 Outcome of parameningeal head and neck rhabdomyosarcoma in adults: Kyushu Medical Oncology Group Study
|
Isobe, Taichi
|
|
|
34 |
S3 |
p. S1409
|
artikel
|
| 148 |
MO63-2 Overall survival for esophageal cancer patients with pembrolizumab: Systematic review
|
Sutanto, Mario
|
|
|
34 |
S3 |
p. S1436
|
artikel
|
| 149 |
MO69-3 Pathological predictors of the response to platinum-based chemotherapy in pancreatobiliary neuroendocrine carcinoma
|
Furukawa, Takaaki
|
|
|
34 |
S3 |
p. S1438
|
artikel
|
| 150 |
MO70-2 Pegfilgrastim with second-line amrubicin for relapsed small cell lung cancer: Single institution experience
|
Shibata, Kazuhiko
|
|
|
34 |
S3 |
p. S1439
|
artikel
|
| 151 |
MO71-5 Pembrolizumab effectiveness in platinum-resistant ovarian carcinoma: Systematic review
|
Law, Natasha Karlina
|
|
|
34 |
S3 |
p. S1440
|
artikel
|
| 152 |
MO11-1 Phase I dose-finding study of the SIRPα inhibitor BI 765063 as monotherapy in Japanese patients with advanced cancer
|
Doi, Toshihiko
|
|
|
34 |
S3 |
p. S1403
|
artikel
|
| 153 |
MO3-3 Phase II study of S-1+CDDP with concurrent TRT followed by durvalumab for unresectable LA-NSCLC in Japan (SAMURAI)
|
Tanzawa, Shigeru
|
|
|
34 |
S3 |
p. S1396
|
artikel
|
| 154 |
MO4-2 Phase 1 study of ABBV-400, a novel anti-Met antibody drug conjugate, in advanced solid tumors
|
Shimizu, Toshio
|
|
|
34 |
S3 |
p. S1397
|
artikel
|
| 155 |
MO38-1 Phase 1 study of ABBV-155 ± paclitaxel in relapsed/refractory solid tumors: Results in Japanese patients
|
Shimizu, Toshio
|
|
|
34 |
S3 |
p. S1420
|
artikel
|
| 156 |
MO50-5 Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma
|
Izutsu, Koji
|
|
|
34 |
S3 |
p. S1428
|
artikel
|
| 157 |
MO21-4 Platelet-lymphocyte ratio as prognostic factor in soft tissue sarcoma
|
Chandra, Amos Immanuel
|
|
|
34 |
S3 |
p. S1410
|
artikel
|
| 158 |
MO8-5 Pneumocystis jiroveci pneumonia in patients receiving ddAC for breast cancer: A single center retrospective study
|
Manako, Chika
|
|
|
34 |
S3 |
p. S1400-S1401
|
artikel
|
| 159 |
MO2-2 Post-marketing observational safety study of durvalumab in Japanese patients with unresectable stage III NSCLC (PACIFIC regimen)
|
Kato, Terufumi
|
|
|
34 |
S3 |
p. S1395
|
artikel
|
| 160 |
MO38-2 Post-marketing surveillance of tepotinib for non-small cell lung cancer with MET exon 14 skipping mutations – final report
|
Kato, Terufumi
|
|
|
34 |
S3 |
p. S1420-S1421
|
artikel
|
| 161 |
MO62-1 Prediction of early lung cancer development using whole lung texture analysis from LDCT
|
Huang, Wei-Ming
|
|
|
34 |
S3 |
p. S1435
|
artikel
|
| 162 |
MO72-3 Predictive factors of post-operative acute kidney injury after CRS-HIPEC in patients with peritoneal carcinomatosis
|
Cabiling, Chito Clarin
|
|
|
34 |
S3 |
p. S1441
|
artikel
|
| 163 |
MO18-6 Predictive value of CDC37 gene expression for regorafenib in metastatic colorectal cancer (mCRC)
|
Arai, Hiroyuki
|
|
|
34 |
S3 |
p. S1407
|
artikel
|
| 164 |
MO50-3 Preliminary data from the phase I/II study of TP-3654, an oral PIM-1 kinase inhibitor, in patients with myelofibrosis
|
El Chaer, Firas
|
|
|
34 |
S3 |
p. S1427
|
artikel
|
| 165 |
MO52-5 Prevalence and clinical features of triple-negative breast cancer in a tertiary government hospital in the Philippines
|
Maano, Omar Paningbatan
|
|
|
34 |
S3 |
p. S1429
|
artikel
|
| 166 |
MO23-3 Primary bony tumors of cranio-cervical junction and upper cervical spine: Management and their outcome from 21 cases
|
Kumarasamy, Sivaraman
|
|
|
34 |
S3 |
p. S1411
|
artikel
|
| 167 |
MO62-7 Prognostic evaluation using cfDNA in patients with resectable lung cancer
|
Murase, Yuya
|
|
|
34 |
S3 |
p. S1436
|
artikel
|
| 168 |
MO35-1 Prognostic evolution of EGFR-mutated non-small cell lung cancer over the past 20 years since the beginning with gefitinib
|
Nakagomi, Takahiro
|
|
|
34 |
S3 |
p. S1418
|
artikel
|
| 169 |
MO55-4 Prognostic impact and predictive biomarkers of immune checkpoint inhibitor-induced interstitial lung disease for non-small cell lung cancer
|
Murata, Daiki
|
|
|
34 |
S3 |
p. S1430
|
artikel
|
| 170 |
MO36-4 Prognostic impact of genetic mutations in unfavorable cancer of unknown primary site
|
Tang, Chengyu
|
|
|
34 |
S3 |
p. S1419
|
artikel
|
| 171 |
MO48-5 Progression of disease within 5 months of adult T-cell leukemia-lymphoma (ATL5) as a clinical endpoint for high-risk mortality outcomes
|
Sano, Haruhiko
|
|
|
34 |
S3 |
p. S1426
|
artikel
|
| 172 |
MO35-6 Prospective exosome-focused translational research for afatinib study of non-small cell lung cancer patients expressing EGFR (EXTRA study)
|
Morikawa, Kei
|
|
|
34 |
S3 |
p. S1418-S1419
|
artikel
|
| 173 |
MO23-6 Prospective study to evaluate the role of bevacizumab in treatment of vestibular schwannoma in neurofibromatosis type 2
|
V, Pavana
|
|
|
34 |
S3 |
p. S1411-S1412
|
artikel
|
| 174 |
MO9-5 Psychological interventions for managing depression among post intervention breast cancer patients: A systematic review
|
Dharmaraja, Fernando
|
|
|
34 |
S3 |
p. S1402
|
artikel
|
| 175 |
MO27-1 Psychosocial risk factors of chronic pain among post-surgical breast cancer survivors: A systematic review
|
Wijovi, Felix
|
|
|
34 |
S3 |
p. S1413
|
artikel
|
| 176 |
MO3-4 Radiotherapy technique recommendation based on radiomics for non-small cell lung cancer (NSCLC) patients
|
Cheung, Eva Y.W.
|
|
|
34 |
S3 |
p. S1397
|
artikel
|
| 177 |
MO56-1 Randomized phase II study of zoledronate dosing every 4 versus 8 weeks in patients with bone metastasis from lung cancer (Hanshin Cancer Group0312)
|
Tamiya, Motohiro
|
|
|
34 |
S3 |
p. S1431
|
artikel
|
| 178 |
MO18-4 RAS status in ctDNA and efficacy of FOLFIRI plus ramucirumab in 2nd-line therapy for RAS wild-type mCRC: JACCRO CC-16AR
|
Sunakawa, Yu
|
|
|
34 |
S3 |
p. S1407
|
artikel
|
| 179 |
MO1-3 Real-world data of first-line treatment with pembrolizumab for NSCLC with high PD-L1 expression (HOT/NJLCG2001 secondary report)
|
Tateishi, Kazunari
|
|
|
34 |
S3 |
p. S1394
|
artikel
|
| 180 |
MO34-1 Real-world evidence of precision medicine for biliary tract cancer
|
Hayashi, Hideyuki
|
|
|
34 |
S3 |
p. S1417
|
artikel
|
| 181 |
MO71-4 Real-world treatment of niraparib as maintenance therapy in patients newly diagnosed advanced ovarian cancer in Japan
|
Shimada, Muneaki
|
|
|
34 |
S3 |
p. S1440
|
artikel
|
| 182 |
MO6-2 Regorafenib plus tislelizumab as first-line systemic therapy for patients with advanced hepatocellular carcinoma (HCC)
|
Chuang, Chienhuai
|
|
|
34 |
S3 |
p. S1398
|
artikel
|
| 183 |
MO33-2 Retrospective analysis of urothelial carcinoma treated with enfortumab vedotin at our institution
|
Imai, Toru
|
|
|
34 |
S3 |
p. S1417
|
artikel
|
| 184 |
MO66-4 Retrospective study of gastric cancer with myelocarcinomatosis: A novel aspect of treatment for disseminated intravascular coagulation
|
Kusano, Wataru
|
|
|
34 |
S3 |
p. S1437
|
artikel
|
| 185 |
MO1-5 Role of immunocheckpoint inhibitors in stage IV non-small cell lung cancer patients <40 years old of age
|
Takamori, Shinkichi
|
|
|
34 |
S3 |
p. S1394
|
artikel
|
| 186 |
MO28-1 Self-care towards the end of life: A systematic review and narrative synthesis on access, quality and cost
|
Gallagher, Joshua
|
|
|
34 |
S3 |
p. S1413
|
artikel
|
| 187 |
MO28-4 Sleeplessness in breast cancer patients: A multicenter prospective observational study
|
Aoki, Takuya
|
|
|
34 |
S3 |
p. S1414
|
artikel
|
| 188 |
MO11-4 Stereotactic body radiotherapy (SBRT) for oligometastases: Real-world outcome in multi-ethnic Asian patients
|
Mohamad, Noor Nabila
|
|
|
34 |
S3 |
p. S1403
|
artikel
|
| 189 |
MO1-6 Steroid-resistant and refractory irAEs requiring additional immunosuppressants to steroids in advanced NSCLC patients
|
Shimoda, Yukiko
|
|
|
34 |
S3 |
p. S1394-S1395
|
artikel
|
| 190 |
MO19-3 Subgroup analyses of phase II study of weekly paclitaxel in advanced esophageal cancer that had previously received docetaxel-containing chemotherapy
|
Nakashima, Koji
|
|
|
34 |
S3 |
p. S1408
|
artikel
|
| 191 |
MO1-2 Subgroup analysis of atezo + bev + carbo + pac for previously treated patients with EGFRm NSCLC (NEJ043)
|
Shiihara, Jun
|
|
|
34 |
S3 |
p. S1393
|
artikel
|
| 192 |
MO71-1 Systematic quantification of ovarian tumour heterogeneity using an in silico tissue microarray approach
|
Reinius, Marika
|
|
|
34 |
S3 |
p. S1439-S1440
|
artikel
|
| 193 |
MO49-7 The clinical impact of chronic hepatitis C infection on hematologic malignancies: A systematic review
|
Lin, Wan-Shiuan
|
|
|
34 |
S3 |
p. S1427
|
artikel
|
| 194 |
MO70-5 The clinical outcomes for anamorelin in advanced gastrointestinal cancer patients with cancer cachexia
|
Nishimura, Ari
|
|
|
34 |
S3 |
p. S1439
|
artikel
|
| 195 |
MO32-6 The development of an expert panel support program using the Python programming language
|
Yamaguchi, Tatsuro
|
|
|
34 |
S3 |
p. S1416-S1417
|
artikel
|
| 196 |
MO49-1 The efficacy of high-dose versus intrathecal methotrexate for DLBCL with high risk of CNS relapse: A multicenter retrospective study
|
Akimoto, Masahiro
|
|
|
34 |
S3 |
p. S1426
|
artikel
|
| 197 |
MO3-6 The elderly subgroup analysis in real world survey (CRIMSON) of concurrent chemoradiotherapy in locally advanced NSCLC
|
Tamiya, Akihiro
|
|
|
34 |
S3 |
p. S1397
|
artikel
|
| 198 |
MO54-4 The impact and development of the shared decision-making in cancer treatment during the COVID-19 pandemic
|
Lin, Wan-Shiuan
|
|
|
34 |
S3 |
p. S1430
|
artikel
|
| 199 |
MO26-4 The impact and emerging issues of confirmation of chemotherapy regimen by a pharmacist in our breast oncology
|
Ozeki, Rie
|
|
|
34 |
S3 |
p. S1413
|
artikel
|
| 200 |
MO40-3 The impact of sarcopenia on adverse events during neoadjuvant chemotherapy in esophageal squamous cell carcinoma
|
Tsuji, Takayuki
|
|
|
34 |
S3 |
p. S1422
|
artikel
|
| 201 |
MO25-1 The impact of sarcopenia on survival and chemotoxicity in metastatic renal cell carcinoma patients: A meta-analysis
|
Tancherla, Angeline
|
|
|
34 |
S3 |
p. S1412
|
artikel
|
| 202 |
MO22-3 The outcomes of glioblastoma multiforme: The University Malaya Medical Centre experience 2008-2018
|
Fa'Izah Ab Muin, Nur
|
|
|
34 |
S3 |
p. S1411
|
artikel
|
| 203 |
MO69-6 The possibility of microtubule-related agents as a new treatment option for neuroendocrine carcinoma and small cell lung cancer
|
Yamaga, Satoru
|
|
|
34 |
S3 |
p. S1439
|
artikel
|
| 204 |
MO29-1 The present activity and issues of AYA support team for the patients in AYA generation
|
Inagaki, Yuichiro
|
|
|
34 |
S3 |
p. S1414-S1415
|
artikel
|
| 205 |
MO43-1 The treatment sequence of weekly paclitaxel, carboplatin, and cetuximab (PCE) followed by nivolumab for R/M SCCHN
|
Takeshita, Naohiro
|
|
|
34 |
S3 |
p. S1424
|
artikel
|
| 206 |
MO19-6 The use of ctDNA analysis in predicting esophageal cancer recurrence: A systematic review and meta-analysis
|
D'Prinzessin, Celine Augla
|
|
|
34 |
S3 |
p. S1408
|
artikel
|
| 207 |
MO66-2 The use of ramucirumab before nivolumab may improve survival for unresectable advanced or recurrent gastric cancer
|
Hirata, Shoichiro
|
|
|
34 |
S3 |
p. S1437
|
artikel
|
| 208 |
MO29-3 Transition of childhood cancer survivors to adult care – what we have learned from the experience of Cancer Survivorship Clinic over the past 3 years
|
Taniyama, Tomoko
|
|
|
34 |
S3 |
p. S1415
|
artikel
|
| 209 |
MO41-6 Trastuzumab-deruxtecan and blood inflammatory markers in HER2-positive metastatic breast cancer
|
Onishi, Mai
|
|
|
34 |
S3 |
p. S1423
|
artikel
|
| 210 |
MO6-6 Treatment effect of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma aiming at curative conversion therapy
|
Tomonari, Tetsu
|
|
|
34 |
S3 |
p. S1399
|
artikel
|
| 211 |
MO53-3 Treatment for older patients with genitourinary cancer at Kyushu Cancer Center
|
Negishi, Takahito
|
|
|
34 |
S3 |
p. S1429
|
artikel
|
| 212 |
MO12-1 Treatment patterns and outcomes in CLL/SLL after BTK inhibitor exposure using a Japanese claims database
|
Kusumoto, Shigeru
|
|
|
34 |
S3 |
p. S1403-S1404
|
artikel
|
| 213 |
MO9-3 Triple-negative and hormone-positive breast cancer: The association with reproductive factors among Bangladeshi women
|
Islam, Muhammad Rafiqul
|
|
|
34 |
S3 |
p. S1401
|
artikel
|
| 214 |
MO60-4 Tryptophan is the prognostic factor in patients with unresectable pancreatic cancer
|
Saito, Kei
|
|
|
34 |
S3 |
p. S1434
|
artikel
|
| 215 |
MO12-3 Tumor-associated macrophage as prognostic indicator in patients with non-Hodgkin’s lymphoma: A systematic review
|
Liem, Jean Andrina
|
|
|
34 |
S3 |
p. S1404
|
artikel
|
| 216 |
MO6-5 Tumor microenvironment and clinical efficacy of atezolizumab plus bevacizumab for hepatocellular carcinoma
|
Taira, Tomonao
|
|
|
34 |
S3 |
p. S1399
|
artikel
|
| 217 |
MO36-2 Updated analysis from a phase II study on the efficacy of nivolumab in patients with cancer of unknown primary (NivoCUP)
|
Funakoshi, Yohei
|
|
|
34 |
S3 |
p. S1419
|
artikel
|
| 218 |
MO45-2 Usefulness of urine dipstick test in the management of adverse events associated with immune checkpoint inhibitors
|
Izumi, Keishiro
|
|
|
34 |
S3 |
p. S1424
|
artikel
|
| 219 |
MO30-1 Validation of a prediction tool for chemotherapy toxicity in older adults with cancer in Ramathibodi Hospital, Thailand
|
Liengudom, Chaninart
|
|
|
34 |
S3 |
p. S1415
|
artikel
|
| 220 |
O1-1 A comparative study of TMB values in comprehensive genomic profiling assays in different gene panels
|
Nishino, Takahiro
|
|
|
34 |
S3 |
p. S1383
|
artikel
|
| 221 |
O2-2 A comparative study on awareness of cervical cancer among female patients in urban and rural areas of Bangladesh
|
Sultana, Farzana
|
|
|
34 |
S3 |
p. S1383-S1384
|
artikel
|
| 222 |
O4-3 An update analysis of the JACCRO CC-16: Ramucirumab plus FOLFIRI for RAS wild-type mCRC refractory to anti-EGFR antibody
|
Manaka, Dai
|
|
|
34 |
S3 |
p. S1385
|
artikel
|
| 223 |
O7-2 A phase II study to assess the efficacy of osimertinib in patients with EGFR MT(+)T790M(-) NSCLC
|
Hayakawa, Daisuke
|
|
|
34 |
S3 |
p. S1387
|
artikel
|
| 224 |
O17-2 A phase II trial of tazemetostat for patients with unresectable or metastatic epithelioid sarcoma (TAZETTA trial)
|
Kita, Shosuke
|
|
|
34 |
S3 |
p. S1392
|
artikel
|
| 225 |
O16-4 A phase 2 trial of nivolumab monotherapy in rare cancer patients with mismatch repair deficiency or MSI-high: ROCK trial (NCCH1709) from MASTER KEY Project
|
Tsuchihashi, Kenji
|
|
|
34 |
S3 |
p. S1391
|
artikel
|
| 226 |
O14-1 A randomized phase II study comparing S-1 plus oxaliplatin with S-1 monotherapy for elderly patients with advanced gastric cancer: WJOG8315G
|
Makiyama, Akitaka
|
|
|
34 |
S3 |
p. S1390
|
artikel
|
| 227 |
O10-3 Association between necitumumab skin toxicity and efficacy in squamous NSCLC: A pooled analysis from SQUIRE and JFCM
|
Yoshioka, Hiroshige
|
|
|
34 |
S3 |
p. S1388-S1389
|
artikel
|
| 228 |
O2-3 Cervical cancer risk factor classifying using data mining and machine learning approach to early diagnosis and treatment
|
Islam, Md Shariful
|
|
|
34 |
S3 |
p. S1384
|
artikel
|
| 229 |
O4-5 Circulating tumor DNA dynamics as an early predictor of recurrence in patients with radically resected colorectal cancer: GALAXY study in the CIRCULATE-Japan
|
Mishima, Saori
|
|
|
34 |
S3 |
p. S1385
|
artikel
|
| 230 |
O6-4 Clinicoimmunological study of sarcomatoid carcinoma across organs
|
Morisue, Ryo
|
|
|
34 |
S3 |
p. S1386
|
artikel
|
| 231 |
O5-3 Expert training workshop on support for balancing cancer treatment and work organized by West Japan Oncology Group
|
Ikeda, Satoshi
|
|
|
34 |
S3 |
p. S1386
|
artikel
|
| 232 |
O16-3 Extending adjuvant temozolomide may increase risk of adverse events while conferring no survival benefits in glioblastoma patients
|
Kai Lau, Arthur Chak
|
|
|
34 |
S3 |
p. S1391
|
artikel
|
| 233 |
O3-1 Financial toxicity and cost-related experience in molecular and immune therapies: A multicenter questionnaire survey
|
Yamamoto, Sena
|
|
|
34 |
S3 |
p. S1384
|
artikel
|
| 234 |
O6-3 Interim results of FIH phase 1 of TAK-102, GPC-3 targeted armored CAR-T therapy in patients with advanced solid tumors
|
Kuboki, Yasutoshi
|
|
|
34 |
S3 |
p. S1386
|
artikel
|
| 235 |
O16-5 Nivolumab for cancer of unknown primary (CUP): Initial results from an expanded access program (NivoCUP2, WJOG14620M)
|
Tanizaki, Junko
|
|
|
34 |
S3 |
p. S1392
|
artikel
|
| 236 |
O15-3 Nivolumab plus ipilimumab (N+I) for potentially resectable hepatocellular carcinoma (HCC): Efficacy and surgical outcome
|
Su, Yung-Yeh
|
|
|
34 |
S3 |
p. S1390
|
artikel
|
| 237 |
O15-4 Outcomes of genetic aberrations and clinical features in cholangiocarcinoma: Report from the MASTER KEY Project
|
Maruki, Yuta
|
|
|
34 |
S3 |
p. S1390
|
artikel
|
| 238 |
O9-1 Paclitaxel plus cetuximab vs. nivolumab for patients with platinum-refractory recurrent/metastatic head and neck cancer
|
Kodama, Hiroyuki
|
|
|
34 |
S3 |
p. S1388
|
artikel
|
| 239 |
O7-4 Phase 1b efficacy of telisotuzumab vedotin and osimertinib in Asian vs non-Asian patients with advanced NSCLC
|
Horinouchi, Hidehito
|
|
|
34 |
S3 |
p. S1387
|
artikel
|
| 240 |
O7-3 Phase II study of brigatinib in patients with TKI-naive ROS1-rearranged non-small cell lung cancer (NSCLC): Barossa study
|
Takahashi, Toshiaki
|
|
|
34 |
S3 |
p. S1387
|
artikel
|
| 241 |
O16-2 Phase I trial of NY-ESO-1 TCR-T cell therapy combined with nanoparticulate vaccine but without lymphodepletion for STS
|
Ishihara, Mikiya
|
|
|
34 |
S3 |
p. S1391
|
artikel
|
| 242 |
O1-2 Prospective study of comprehensive genomic profiling for chemotherapy-naive cancer patients (FIRST-Dx study)
|
Ebi, Hiromichi
|
|
|
34 |
S3 |
p. S1383
|
artikel
|
| 243 |
O2-5 Quality of sex in cervical cancer survivors post-treatment: A systematic review
|
Angel, Patricia
|
|
|
34 |
S3 |
p. S1384
|
artikel
|
| 244 |
O8-1 Real-world anamorelin use in 4,672 patients with cancer cachexia; Results from post-marketing all-case surveillance
|
Muro, Kei
|
|
|
34 |
S3 |
p. S1387-S1388
|
artikel
|
| 245 |
O13-5 Rejuvenated BCMA-specific CD8αβ+ memory T cells to treat multiple myeloma using induced pluripotent stem cell technology
|
Bae, Jooeun
|
|
|
34 |
S3 |
p. S1389-S1390
|
artikel
|
| 246 |
O5-1 Reliability and validity of the Japanese version of the Chemotherapy-induced Alopecia Distress Scale
|
Aoyama, Yosuke
|
|
|
34 |
S3 |
p. S1385-S1386
|
artikel
|
| 247 |
O9-2 Salvage chemotherapy with paclitaxel plus cetuximab (PE)-based regimen following immune checkpoint inhibitor in R/M SCCHN
|
Tanaka, Hideki
|
|
|
34 |
S3 |
p. S1388
|
artikel
|
| 248 |
O1-3 Selection bias due to left-truncation in comprehensive genomic profiling test and differences between Japan and the United States
|
Ikegami, Masachika
|
|
|
34 |
S3 |
p. S1383
|
artikel
|
| 249 |
O13-3 Subcutaneous epcoritamab in Japanese patients with relapsed/refractory diffuse large B-cell lymphoma: EPCORE NHL-3 data
|
Izutsu, Koji
|
|
|
34 |
S3 |
p. S1389
|
artikel
|
| 250 |
O10-2 Telisotuzumab vedotin monotherapy in Asian patients with c-Met–overexpressing advanced non-small cell lung cancer
|
Horinouchi, Hidehito
|
|
|
34 |
S3 |
p. S1388
|
artikel
|
| 251 |
O3-4 Umbrella reviews of systematic reviews assessing pelvic floor muscle training on post-radical prostatectomy incontinence
|
Lin, Wan-Shiuan
|
|
|
34 |
S3 |
p. S1384-S1385
|
artikel
|
| 252 |
O13-4 2-year update of KTE-X19 in adults with relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) in ZUMA-3
|
Shah, Bijal D.
|
|
|
34 |
S3 |
p. S1389
|
artikel
|
| 253 |
P43-3 A case of complete response to entrectinib in NTRK fusion gene-positive parotid carcinoma
|
Moriyama, Etsuko
|
|
|
34 |
S3 |
p. S1457-S1458
|
artikel
|
| 254 |
P21-7 A case of male breast cancer with long-term disease control with fulvestrant + abemaciclib
|
Takahashi, Miyuki
|
|
|
34 |
S3 |
p. S1449-S1450
|
artikel
|
| 255 |
P53-2 A case of metastatic prostate cancer mimicking malignant lymphoma
|
Itagaki, Nae
|
|
|
34 |
S3 |
p. S1460
|
artikel
|
| 256 |
P19-10 A case of non-invasive therapy for unresectable desmoid fibromatosis with perforation of the gastrointestinal tract
|
Miyake, Hiroaki
|
|
|
34 |
S3 |
p. S1448
|
artikel
|
| 257 |
P45-5 A case report of pneumothorax after treatment with bevacizumab-containing chemotherapy for metastatic breast cancer
|
Suzuki, Hitomi
|
|
|
34 |
S3 |
p. S1459
|
artikel
|
| 258 |
P57-5 A case report of primary unresectable hilar cholangiocarcinoma eventually causing colonic obstruction due to peritoneal dissemination after chemoradiation
|
Toyofuku, Atsushi
|
|
|
34 |
S3 |
p. S1462-S1463
|
artikel
|
| 259 |
P19-9 Acinar cell carcinoma of the pancreas: A case report
|
Kamolrat, Nuttawut
|
|
|
34 |
S3 |
p. S1448
|
artikel
|
| 260 |
P29-10 Actionable genomic alterations in Filipino cancer patients using next-generation sequencing (NGS) liquid biopsy test
|
Cruz Ordinario, Mel Valerie
|
|
|
34 |
S3 |
p. S1452-S1453
|
artikel
|
| 261 |
P25-10 Advanced NSCLC patients: Comparison between those with and without brain metastases
|
Techasatian, Tanwimon
|
|
|
34 |
S3 |
p. S1451
|
artikel
|
| 262 |
P40-7 Anal neuroendocrine carcinoma masquerading external hemorrhoid: Case report of a rare and aggressive malignancy
|
Sookthon, Chatsuda
|
|
|
34 |
S3 |
p. S1457
|
artikel
|
| 263 |
P10-1 Analysis of thromboembolism and prognosis in metastatic pancreatic cancer: A secondary analysis of Tokushukai REAl-world Data project 03-S1
|
Shimoyama, Rai
|
|
|
34 |
S3 |
p. S1445
|
artikel
|
| 264 |
P19-7 An asymptomatic steroid cell tumor of ovary – A rare case report
|
Zaid, Rizma Mohd
|
|
|
34 |
S3 |
p. S1448
|
artikel
|
| 265 |
P32-8 An inter-facility linkage case for palliative care and cancer pharmacotherapy in the Kagawa Medical Information Network
|
Murakami, Akitsu
|
|
|
34 |
S3 |
p. S1454
|
artikel
|
| 266 |
P63-3 A pivotal role of interdisciplinary team medicine in lenvatinib plus pembrolizumab therapy against advanced endometrial cancer
|
Sonoda, Kenzo
|
|
|
34 |
S3 |
p. S1463
|
artikel
|
| 267 |
P58-8 A rare case of bleomycin-induced severe skin reactions: A case reports and literature review
|
Ariful Islam, Syed Mohammad
|
|
|
34 |
S3 |
p. S1463
|
artikel
|
| 268 |
P66-5 A rare case of phylloides tumor of overt treatment with radiotherapy of a female breast cancer patient in Bangladesh
|
Islam, Noorjahan
|
|
|
34 |
S3 |
p. S1465
|
artikel
|
| 269 |
P31-9 A retrospective study of elderly and non-elderly patients with metastatic pancreatic cancer treated with GEM+nab-PTX therapy
|
Kawamoto, Yasuyuki
|
|
|
34 |
S3 |
p. S1453
|
artikel
|
| 270 |
P22-2 A single center treatment experience of combination with chemotherapy and nivolumab for HER2-negative gastric cancer
|
Tsugaru, Kai
|
|
|
34 |
S3 |
p. S1450
|
artikel
|
| 271 |
P54-3 AS101 inhibits tumor metastasis by down-regulation of heparanase
|
Wenjun, Fan
|
|
|
34 |
S3 |
p. S1461
|
artikel
|
| 272 |
P29-8 A study of lung cancer cases who participated in cancer genome medicine at our hospital
|
Sumii, Masahiko
|
|
|
34 |
S3 |
p. S1452
|
artikel
|
| 273 |
P44-1 A study of 11 patients treated with trastuzumab deruxtecan including those with interstitial lung disease
|
Higuchi, Toru
|
|
|
34 |
S3 |
p. S1458-S1459
|
artikel
|
| 274 |
P65-3 Attitudes and job demand among nurses toward medical oncology clinical trials: Exploration of the component factors
|
Osawa, Shino
|
|
|
34 |
S3 |
p. S1465
|
artikel
|
| 275 |
P13-5 Autologous transplantation with thiotepa and busulfan for primary neurolymphomatosis with CNS involvement
|
Araie, Hiroaki
|
|
|
34 |
S3 |
p. S1447
|
artikel
|
| 276 |
P55-2 BRCA2 reversion mutations as a resistance mechanism of olaparib in patients with BRCA2-associated mCRPC
|
Takemura, Kohji
|
|
|
34 |
S3 |
p. S1461-S1462
|
artikel
|
| 277 |
P8-5 Calculation of medical personnel expenses to conduct a comprehensive genomic profiling test in Japan
|
Kage, Hidenori
|
|
|
34 |
S3 |
p. S1445
|
artikel
|
| 278 |
P43-5 Case report: Clear cell carcinoma of urethra
|
Tuitemwong, Pimchanok
|
|
|
34 |
S3 |
p. S1458
|
artikel
|
| 279 |
P27-5 Case report: Efficacy of platinum in metastatic castration-resistant prostate cancer (mCRPC) with BRCA2 mutation
|
Palanupap, Kanokrat
|
|
|
34 |
S3 |
p. S1451
|
artikel
|
| 280 |
P63-5 Cases of atypical femur fractures; the rare adverse events requiring the multidisciplinary team decision-making
|
Kanehira, Dan
|
|
|
34 |
S3 |
p. S1464
|
artikel
|
| 281 |
P20-3 CDK1 expression in breast cancer
|
Lim, Yueh Ni
|
|
|
34 |
S3 |
p. S1449
|
artikel
|
| 282 |
P18-7 Chemotherapy for advanced urachal carcinoma: A case series of three patients
|
Kitazono, Takafumi
|
|
|
34 |
S3 |
p. S1448
|
artikel
|
| 283 |
P26-9 Clinical outcome of nivolumab and ipilimumab in untreated advanced non-small cell lung cancer patients
|
Sugimoto, Akira
|
|
|
34 |
S3 |
p. S1451
|
artikel
|
| 284 |
P30-1 Comparison of efficacy of atezolizumab and bevacizumab treatment for hepatocellular carcinoma between tyrosine kinase inhibitor-naive and -experienced patients
|
Nishijima, Norihiro
|
|
|
34 |
S3 |
p. S1453
|
artikel
|
| 285 |
P65-1 Development of genome data repository system for big data utilization and secure storage
|
Amano, Toraji
|
|
|
34 |
S3 |
p. S1464
|
artikel
|
| 286 |
P3-5 DLBCL developed during the immune checkpoint inhibitor therapy in a patient with advanced gastric cancer
|
Takamizawa, Shigemasa
|
|
|
34 |
S3 |
p. S1443
|
artikel
|
| 287 |
P64-2 Durable response and adverse events in a patient with non-MSI-H uterine clear cell carcinoma on pembrolizumab/lenvatinib
|
Chan, Jack Junjie
|
|
|
34 |
S3 |
p. S1464
|
artikel
|
| 288 |
P9-2 Effect of Ayurveda based CAM therapy on quality of life in elderly patient with hepatic cell carcinoma
|
Bendale, Yogesh
|
|
|
34 |
S3 |
p. S1466
|
artikel
|
| 289 |
P11-4 Efficacy and safety of anti-CD38 antibodies in combination with pomalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma
|
Sato, Tsuyoshi
|
|
|
34 |
S3 |
p. S1446
|
artikel
|
| 290 |
P50-5 Efficacy and safety of CBDCA/ETP/ICI combination therapy for extensive-stage small cell lung cancer in elderly patients
|
Fukasawa, Naoto
|
|
|
34 |
S3 |
p. S1460
|
artikel
|
| 291 |
P12-3 Eficacy and mortality of venetoclax as promising treatment for acute myeloid leukemia: Systematic review
|
Kosayuz, Sherina
|
|
|
34 |
S3 |
p. S1446-S1447
|
artikel
|
| 292 |
P28-6 Evaluation of PDT efficacy by an intense pulsed laser in breast cancer spheroids in simulated hormonal microenvironment
|
Chu, Ellie Sm
|
|
|
34 |
S3 |
p. S1452
|
artikel
|
| 293 |
P56-11 Evaluation of the nematode C. elegans cancer test (N-NOSE) in thyroid cancer
|
Miwa, Keisuke
|
|
|
34 |
S3 |
p. S1462
|
artikel
|
| 294 |
P18-5 Examination of the sequence of chemotherapy regimen in malignant pleural mesothelioma
|
Negi, Yoshiki
|
|
|
34 |
S3 |
p. S1447
|
artikel
|
| 295 |
P47-1 FOLFOXIRI therapy with bevacizumab in metastatic colorectal cancer patient: Systematic review
|
Theodeus Subroto, Dion Ravinder
|
|
|
34 |
S3 |
p. S1459
|
artikel
|
| 296 |
P34-6 Function of a HER2 VUS in colorectal cancer with APC mutations and its potential for HER2-targeted therapy
|
Mitani, Yosuke
|
|
|
34 |
S3 |
p. S1455
|
artikel
|
| 297 |
P2-3 Gastric adenocarcinoma in adolescents and young adults: Patterns of care and survival in the Singapore
|
Yeo, Dylan
|
|
|
34 |
S3 |
p. S1443
|
artikel
|
| 298 |
P34-2 Half dose pegfilgrastim for patients with breast cancer during chemotherapy: A case-series study
|
Ikeda, Mako
|
|
|
34 |
S3 |
p. S1454
|
artikel
|
| 299 |
P64-4 HER2-directed therapies beyond progression in a patient with recurrent HER2-positive mucinous ovarian carcinoma
|
Chan, Jack Junjie
|
|
|
34 |
S3 |
p. S1464
|
artikel
|
| 300 |
P12-2 Hypomethylating agent as first-line treatment for acute myeloid leukemia: Systematic review
|
Jhoputri, Caroline Fricilia
|
|
|
34 |
S3 |
p. S1446
|
artikel
|
| 301 |
P12-1 Hypomethylating agent for acute myeloid leukemia, the efficacy and its effect towards mortality rate: Systematic review
|
Tandokallo, Felicia
|
|
|
34 |
S3 |
p. S1446
|
artikel
|
| 302 |
P12-9 Ibrutinib combined with venetoclax treatment outcome in chronic lymphocytic leukemia: A systematic review
|
Sugianto, Jeremy Octavian
|
|
|
34 |
S3 |
p. S1447
|
artikel
|
| 303 |
P37-7 Influence of cytosol calcium ion level on PDT efficacy in nasopharyngeal carcinoma cell line
|
Wu, Ricky Wk
|
|
|
34 |
S3 |
p. S1455-S1456
|
artikel
|
| 304 |
P45-8 Iris metastasis as the initial presentation of male breast cancer: A case report
|
Sainamthip, Panot
|
|
|
34 |
S3 |
p. S1459
|
artikel
|
| 305 |
P42-1 Malignant pleural mesothelioma first presenting as cutaneous metastases: A case report
|
Bondoc Pineda, Angelica Marie
|
|
|
34 |
S3 |
p. S1457
|
artikel
|
| 306 |
P67-1 Metastatic patterns based on breast cancer subtypes: A study in a private Indonesian cancer hospital
|
Tenggara, Jeffry Beta
|
|
|
34 |
S3 |
p. S1465
|
artikel
|
| 307 |
P36-3 Mixed learning improved learning outcome in clinical placement in radiation therapy education
|
Cheung, Eva Y.W.
|
|
|
34 |
S3 |
p. S1455
|
artikel
|
| 308 |
P45-1 Neoadjuvant pembrolizumab for triple-negative breast cancer in 26-year-old woman: A South East Asian perspective
|
Firsty, Naufal Nandita
|
|
|
34 |
S3 |
p. S1459
|
artikel
|
| 309 |
P49-1 Next-generation sequencing discordant ALK-rearrangement in non-small cell lung carcinoma with ovarian metastases
|
Lay Tan, Charles Jeffrey
|
|
|
34 |
S3 |
p. S1460
|
artikel
|
| 310 |
P22-1 Nivolumab combination chemotherapy (NC) for HER2-negative, unresectable, advanced, or recurrent gastric cancer (AGC): A retrospective observational study
|
Chikaishi, Wakana
|
|
|
34 |
S3 |
p. S1450
|
artikel
|
| 311 |
P47-7 Oral 5-FU+/-bevacizumab should be basically used for first-line chemotherapy for elderly colorectal cancerous patients
|
Kobayashi, Kazuma
|
|
|
34 |
S3 |
p. S1460
|
artikel
|
| 312 |
P67-5 Our experience with immune checkpoint inhibitors in triple-negative breast cancer patients
|
Nishio, Minako
|
|
|
34 |
S3 |
p. S1465
|
artikel
|
| 313 |
P24-3 Oxaliplatin desensitization therapy in patients with colorectal cancer
|
Sato, Michiko
|
|
|
34 |
S3 |
p. S1450
|
artikel
|
| 314 |
P38-8 Phase 1/2 study of menin inhibitor DSP-5336 in acute leukemia with and without MLL rearrangement or NPM1 mutation
|
Daver, Naval
|
|
|
34 |
S3 |
p. S1456
|
artikel
|
| 315 |
P40-2 Photodynamic therapy (PDT) on adult brain cancer glioblastoma multiforme (GBM): A systematic review
|
Suntoro, Vanessa Angelica
|
|
|
34 |
S3 |
p. S1456
|
artikel
|
| 316 |
P37-6 Potential radiosensitizers for betel nuts-related head and neck squamous cell carcinoma in Taiwan
|
Chen, Jo-Pai
|
|
|
34 |
S3 |
p. S1455
|
artikel
|
| 317 |
P31-8 Predictors of vulnerability to nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer
|
Iede, Kiyotsugu
|
|
|
34 |
S3 |
p. S1453
|
artikel
|
| 318 |
P7-10 Primary mucoepidermoid carcinoma of the lung: A case report
|
Techasatian, Tanwimon
|
|
|
34 |
S3 |
p. S1444
|
artikel
|
| 319 |
P41-6 Primary splenic angiosarcoma: A case report
|
Tamtai, Amorn
|
|
|
34 |
S3 |
p. S1457
|
artikel
|
| 320 |
P25-3 Prognostic impact of concomitant antacids in EGFR-mutation-positive NSCLC: The Tokushukai REAl-world Data project (TREAD 01-S2)
|
Uryu, Kiyoaki
|
|
|
34 |
S3 |
p. S1450
|
artikel
|
| 321 |
P10-2 Prognostic value of systemic inflammation in patients undergoing 1st-line chemotherapy for metastatic pancreatic cancer: Tokushukai REAl-world Data project
|
Shimoyama, Rai
|
|
|
34 |
S3 |
p. S1445-S1446
|
artikel
|
| 322 |
P59-3 Psychiatric adverse effects of corticosteroid among cancer patients: Systematic review of case report, prospective study
|
Sanjaya, Gisela Meydilin
|
|
|
34 |
S3 |
p. S1463
|
artikel
|
| 323 |
P21-2 RAD51D germline pathogenic variant in a young Filipino female with breast cancer: A case report
|
Mendoza Lalusis, John Kelvin
|
|
|
34 |
S3 |
p. S1449
|
artikel
|
| 324 |
P43-1 Radiotherapy treatment in recurrent malignant proliferating trichilemmal tumour: A case report
|
Salimin, Norhidayu
|
|
|
34 |
S3 |
p. S1457
|
artikel
|
| 325 |
P57-1 Real-world treatment outcomes of metastatic biliary tract cancer in Japan: Tokushukai REAl-world Data project; TREAD 04
|
Shimoyama, Rai
|
|
|
34 |
S3 |
p. S1462
|
artikel
|
| 326 |
P31-3 Real-world treatment outcomes of nal-IRI+5FU/LV in unresectable pancreatic cancer
|
Kobayashi, Yuka
|
|
|
34 |
S3 |
p. S1453
|
artikel
|
| 327 |
P17-6 Report of the Cancer Salon at Jichi Medical University Hospital – the 8th report
|
Yamamoto, Rie
|
|
|
34 |
S3 |
p. S1447
|
artikel
|
| 328 |
P40-3 Retrospective analysis of amrubicin therapy for advanced or recurrent neuroendocrine carcinoma in our facility
|
Tsunoda, Akira
|
|
|
34 |
S3 |
p. S1456
|
artikel
|
| 329 |
P4-1 Retrospective analysis of ICIs treatment for the recurrence after CRT and durvalumab maintenance therapy
|
Tsurumi, Kyoji
|
|
|
34 |
S3 |
p. S1444
|
artikel
|
| 330 |
P29-9 Retrospective study of comprehensive cancer genomic profile (CGP) testing for pancreatic cancer
|
Nomura, Mitsutoshi
|
|
|
34 |
S3 |
p. S1452
|
artikel
|
| 331 |
P57-2 Retrospective study of second-line FOLFOX versus S1 for advanced biliary tract cancer
|
Chida, Akihiko
|
|
|
34 |
S3 |
p. S1462
|
artikel
|
| 332 |
P37-5 Role of carotid glomus in the pathophysiology of postoperative hemorrhage in thyroid surgery: An experimental study
|
Vabalayte, Kristina
|
|
|
34 |
S3 |
p. S1455
|
artikel
|
| 333 |
P54-2 Salmonella inhibition tumor metastasis by down-regulation of adrenoceptor beta 3
|
Huang, Yuting
|
|
|
34 |
S3 |
p. S1461
|
artikel
|
| 334 |
PS4-1 Atezolizumab following definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma
|
Ooki, Akira
|
|
|
34 |
S3 |
p. S1381
|
artikel
|
| 335 |
PS3-2 Brexucabtagene autoleucel in relapsed/refractory mantle cell lymphoma (R/R MCL) in ZUMA-2: Durable responder analysis
|
Munoz, Javier
|
|
|
34 |
S3 |
p. S1380
|
artikel
|
| 336 |
PS4-4 Early tumor shrinkage and depth of response with first-line panitumumab or bevacizumab and mFOLFOX treatment in PARADIGM
|
Muro, Kei
|
|
|
34 |
S3 |
p. S1382
|
artikel
|
| 337 |
P27-9 Severe hypocalcemia due to osteoblastic metastases in a patient with metastatic prostate cancer: A case report
|
Tamamritkul, Ratchanon
|
|
|
34 |
S3 |
p. S1451
|
artikel
|
| 338 |
PS1-2 First report of cohort 3 and mature survival data from the U31402-A-U102 study of HER3-DXd in EGFR-mutated NSCLC
|
Hayashi, Hidetoshi
|
|
|
34 |
S3 |
p. S1379
|
artikel
|
| 339 |
PS3-5 Futibatinib for intrahepatic cholangiocarcinoma with FGFR2 fusions/rearrangements: Japanese sub-analysis of FOENIX-CCA2
|
Morizane, Chigusa
|
|
|
34 |
S3 |
p. S1380
|
artikel
|
| 340 |
P55-1 Sonication improved the sensitivity of the MALDI-TOF MS for bacterial identification from direct urine samples
|
Tik, Cheung Ka
|
|
|
34 |
S3 |
p. S1461
|
artikel
|
| 341 |
PS4-2 PD-1 blockade as curative intent therapy in mismatch repair deficient locally advanced rectal cancer
|
Cercek, Andrea
|
|
|
34 |
S3 |
p. S1381
|
artikel
|
| 342 |
PS3-3 Pembrolizumab + chemoradiation therapy for locally advanced head and neck squamous cell carcinoma (HNSCC): KEYNOTE-412
|
Tahara, Makoto
|
|
|
34 |
S3 |
p. S1380
|
artikel
|
| 343 |
PS2-4 Phase 1/2 study of HER3-DXd in HER3-expressing metastatic breast cancer: Subgroup analysis by HER2 expression
|
Iwata, Hiroji
|
|
|
34 |
S3 |
p. S1379
|
artikel
|
| 344 |
PS4-3 Survival analysis of m-FOLFOXIRI plus cetuximab vs. bevacizumab in RAS wild-type mCRC: The DEEPER trial (JACCRO CC-13)
|
Tsuji, Akihito
|
|
|
34 |
S3 |
p. S1381
|
artikel
|
| 345 |
PS2-2 T-DXd vs TPC in patients with HER2-low unresectable and/or metastatic BC in Asian subgroup: Results of DESTINY-Breast04
|
Tsurutani, Junji
|
|
|
34 |
S3 |
p. S1379
|
artikel
|
| 346 |
PSY03-3 Claudin 18.2-targeted therapy for gastric and GEJ adenocarcinoma
|
Shitara, Kohei
|
|
|
34 |
S3 |
p. S1355
|
artikel
|
| 347 |
PSY01-3 Financial toxicity of cancer treatment: From measurement to solutions
|
Gyawali, Bishal
|
|
|
34 |
S3 |
p. S1355
|
artikel
|
| 348 |
P43-7 Synchronous invasive breast cancer and colon adenocarcinoma in a 57-year-old Filipino male
|
Miro, John Michael
|
|
|
34 |
S3 |
p. S1458
|
artikel
|
| 349 |
PSY03-2 Perspective on emerging biomarker-driven therapies in gastric cancer, FGFR2 and beyond
|
Wainberg, Zev A.
|
|
|
34 |
S3 |
p. S1355
|
artikel
|
| 350 |
PSY02-1 The power of patient engagement in drug development for rare cancers: Rationale for research co-creation, and mapping the current landscape
|
Oliver, Kathy Rose
|
|
|
34 |
S3 |
p. S1355
|
artikel
|
| 351 |
P5-2 The addition of atezolizumab to chemotherapy in non-small cell lung cancer: Trial-based review and meta analysis
|
Fitri, Nadya Keumala
|
|
|
34 |
S3 |
p. S1444
|
artikel
|
| 352 |
P2-1 The association between capsaicin consumption and risk of developing gastrointestinal cancer: Systematic review
|
Sutanto, Riona
|
|
|
34 |
S3 |
p. S1443
|
artikel
|
| 353 |
P20-2 The potency of utilization ANLC lipid nanoparticle technology from grapes extract in the management of breast cancer
|
Raditya Adi Kusuma, Pande Ketut
|
|
|
34 |
S3 |
p. S1449
|
artikel
|
| 354 |
P32-2 The role of early palliative care in increasing quality of life in patients with advanced cancer: A systematic review
|
Argo, Teresa Mika
|
|
|
34 |
S3 |
p. S1454
|
artikel
|
| 355 |
P43-9 The treatment of Kaposi sarcoma: Chasing the progressive disease with the presentation of KICS
|
Eiamprapaporn, Panuch
|
|
|
34 |
S3 |
p. S1458
|
artikel
|
| 356 |
P8-3 Time course of cancer genome panels at Osaka Red Cross Hospital
|
Shimada, Takanobu
|
|
|
34 |
S3 |
p. S1444
|
artikel
|
| 357 |
P21-3 Trastuzumab deruxtecan-induced interstitial lung disease in a Filipino female patient with metastatic breast cancer
|
Lim, Robyn Sy
|
|
|
34 |
S3 |
p. S1449
|
artikel
|
| 358 |
P2-2 Treatment outcome of gastric cancer in University Malaya Medical Centre (UMMC)
|
Lim, Yi Way
|
|
|
34 |
S3 |
p. S1443
|
artikel
|
| 359 |
P54-1 Tribbles pseudokinase 3 contributes cancer stemness in head and neck cancer cells by supporting SOX2 and EGFR expression
|
Chang, Wen-Wei
|
|
|
34 |
S3 |
p. S1461
|
artikel
|
| 360 |
P58-4 Two cases of sarcoma needing differentiation from hematopoietic tumor
|
Aramaki, Hiroe
|
|
|
34 |
S3 |
p. S1463
|
artikel
|
| 361 |
P33-7 Two patients with DLBCL who developed aortitis following pegfilgrastim administration during chemoimmunotherapy
|
Tamba, Mikako
|
|
|
34 |
S3 |
p. S1454
|
artikel
|
| 362 |
P8-10 WGS analysis of Erbb2-amplified cervical cancer with two simultaneous histologic types: Transdifferentiation hypothesis
|
Ikushima, Hiroaki
|
|
|
34 |
S3 |
p. S1445
|
artikel
|
| 363 |
SJS-1 An overview of geriatric oncology in global clinical practice: A SIOG national representatives’ survey
|
Mizutani, Tomonori
|
|
|
34 |
S3 |
p. S1352
|
artikel
|
| 364 |
SJS-3 Geriatric oncology in Australia
|
Lane, Heather Patricia
|
|
|
34 |
S3 |
p. S1352
|
artikel
|
| 365 |
Society Pages
|
|
|
|
34 |
S3 |
p. vi-vii
|
artikel
|
| 366 |
SY23-1 Antibody-drug conjugates (ADCs) in treatment-resistant cancers: From basic to clinical applications
|
Yonesaka, Kimio
|
|
|
34 |
S3 |
p. S1370
|
artikel
|
| 367 |
SY12-1 Assessment on clinical validity of PD-L1 assays in lung cancer
|
Yatabe, Yasushi
|
|
|
34 |
S3 |
p. S1361
|
artikel
|
| 368 |
SY05-5 Clinical trials for advanced or recurrent cervical cancer
|
Kim, Jae-Weon
|
|
|
34 |
S3 |
p. S1358
|
artikel
|
| 369 |
SY05-3 Controversies in the surgical treatment for local recurrent cervical cancer
|
Takekuma, Munetaka
|
|
|
34 |
S3 |
p. S1358
|
artikel
|
| 370 |
SY05-2 Current controversies in systemic therapies for advanced or recurrent cervical cancer
|
Chan, Jack Junjie
|
|
|
34 |
S3 |
p. S1358
|
artikel
|
| 371 |
SY13-2 Current evidences in the first-line treatment of metastatic non-clear cell renal cell carcinoma
|
Inokuchi, Junichi
|
|
|
34 |
S3 |
p. S1362
|
artikel
|
| 372 |
SY05-1 Current management of recurrent/metastatic cervical cancer
|
Tewari, Krishnansu Sujata
|
|
|
34 |
S3 |
p. S1358
|
artikel
|
| 373 |
SY19-2 Current progress in treatment strategy for recurrent or metastatic head and neck cancer
|
Licitra, Lisa
|
|
|
34 |
S3 |
p. S1368
|
artikel
|
| 374 |
SY15-2 Current status and challenges of treatment for retroperitoneal sarcoma in Japan
|
Honda, Kazunori
|
|
|
34 |
S3 |
p. S1365
|
artikel
|
| 375 |
SY14-5 Current status and future perspectives of genetic testing and therapy for hereditary tumors in pancreatic cancer
|
Kawamoto, Yasuyuki
|
|
|
34 |
S3 |
p. S1364
|
artikel
|
| 376 |
SY17-3 Current status and future perspectives of treatment for advanced gastroenteropancreatic neuroendocrine neoplasms
|
Fujimori, Nao
|
|
|
34 |
S3 |
p. S1366
|
artikel
|
| 377 |
SY22-3 Current status and prospects of novel molecular targeted therapy in AML
|
Hosono, Naoko
|
|
|
34 |
S3 |
p. S1369
|
artikel
|
| 378 |
SY14-2 Current status of first-line treatment of metastatic pancreatic cancer
|
Ozaka, Masato
|
|
|
34 |
S3 |
p. S1363
|
artikel
|
| 379 |
SY14-1 Current status of pancreatic cancer treatment in Europe
|
Macarulla, Teresa
|
|
|
34 |
S3 |
p. S1363
|
artikel
|
| 380 |
SY23-3 Enfotulumab vedotin treatment, a novel ADC for urothelial carcinoma
|
Uemura, Motohide
|
|
|
34 |
S3 |
p. S1370
|
artikel
|
| 381 |
SY17-1 Evidence and clinical practice of peptide receptor radionuclide therapy for unresectable neuroendocrine tumors
|
Kobayashi, Noritoshi
|
|
|
34 |
S3 |
p. S1366
|
artikel
|
| 382 |
SY01-1 Future perspectives of molecular targets for GI cancer: Future of novel targets in advanced gastric cancer
|
Rha, Sun Young
|
|
|
34 |
S3 |
p. S1356
|
artikel
|
| 383 |
SY28-1 Historical overview of cancer cachexia management
|
Naito, Tateaki
|
|
|
34 |
S3 |
p. S1373
|
artikel
|
| 384 |
SY19-1 How to integrate immunotherapy into treatment strategy for locally advanced head and neck cancer
|
Cohen, Ezra E.W.
|
|
|
34 |
S3 |
p. S1368
|
artikel
|
| 385 |
SY18-KL Incorporation of checkpoint inhibitors into first-line therapy for oesophageal cancer
|
Chau, Ian
|
|
|
34 |
S3 |
p. S1367
|
artikel
|
| 386 |
SY14-3 Landscape and future perspectives of second-line chemotherapy for metastatic pancreatic cancer
|
Imaoka, Hiroshi
|
|
|
34 |
S3 |
p. S1363
|
artikel
|
| 387 |
SY15-4 MASTER KEY Project Japan and MASTER KEY Asia; an Asian platform for rare cancers
|
Okuma, Hitomi
|
|
|
34 |
S3 |
p. S1365
|
artikel
|
| 388 |
SY17-2 Medical treatment in pancreatic and gastrointestinal neuroendocrine neoplasm
|
Hijioka, Susumu
|
|
|
34 |
S3 |
p. S1366
|
artikel
|
| 389 |
SY03-2 Molecular imaging unveils realistic features of T cell activation signaling via TCRs, costimulatory and coinhibitory receptors and CARs
|
Yokosuka, Tadashi
|
|
|
34 |
S3 |
p. S1357
|
artikel
|
| 390 |
SY13-4 Novel combinations in progress in renal cancer
|
Powles, Thomas
|
|
|
34 |
S3 |
p. S1362
|
artikel
|
| 391 |
SY06-1 Optimal therapy concepts in premenopausal patients with HR+ HER2- early breast cancer
|
Harbeck, Nadia
|
|
|
34 |
S3 |
p. S1359
|
artikel
|
| 392 |
SY12-3 PD-L1 test for head and neck cancer and esophageal cancer
|
Fujii, Satoshi
|
|
|
34 |
S3 |
p. S1361
|
artikel
|
| 393 |
SY12-2 PD-L1 testing in breast cancer
|
Horii, Rie
|
|
|
34 |
S3 |
p. S1361
|
artikel
|
| 394 |
SY12-4 PD-L1 testing in gastric cancer
|
Ushiku, Tetsuo
|
|
|
34 |
S3 |
p. S1361
|
artikel
|
| 395 |
SY01-2 Potential molecular targets for colorectal cancer based on recent genome-wide molecular classification
|
Kikuchi, Osamu
|
|
|
34 |
S3 |
p. S1356
|
artikel
|
| 396 |
SY14-4 Recent treatment strategy for locally advanced pancreatic cancer
|
Kanai, Masashi
|
|
|
34 |
S3 |
p. S1363
|
artikel
|
| 397 |
SY15-1 Reference centers and precision medicine trials in sarcoma
|
Blay, Jean-Yves
|
|
|
34 |
S3 |
p. S1365
|
artikel
|
| 398 |
SY27-4 Statistical challenges when selecting primary endpoint(s) in perioperative RCTs in NSCLC
|
Nomura, Shogo
|
|
|
34 |
S3 |
p. S1372
|
artikel
|
| 399 |
SY13-1 Strategies for favorable group of metastasis renal cell carcinoma
|
Oki, Ryosuke
|
|
|
34 |
S3 |
p. S1362
|
artikel
|
| 400 |
SY24-1 The future of platform trials
|
Dodd, Lori E.
|
|
|
34 |
S3 |
p. S1371
|
artikel
|
| 401 |
SY17-4 Therapeutic development for gastroenteropancreatic neuroendocrine neoplasms
|
Chen, Ming-Huang
|
|
|
34 |
S3 |
p. S1366
|
artikel
|
| 402 |
SY13-3 The role of deferred cytoreductive nephrectomy in the era of immune checkpoint inhibitor
|
Yaegashi, Hiroshi
|
|
|
34 |
S3 |
p. S1362
|
artikel
|
| 403 |
SY09-3 The role of fluoropyrimidines in HER2-negative early breast cancer
|
Watanabe, Satomi
|
|
|
34 |
S3 |
p. S1360
|
artikel
|
| 404 |
SY06-4 The sensitivity to chemotherapy for breast cancer in premenopausal women: Differences from postmenopausal women and reasons for the differences
|
Yoshinami, Tetsuhiro
|
|
|
34 |
S3 |
p. S1359
|
artikel
|
| 405 |
SY03-4 TIGIT blockade therapy from basic insights to clinics
|
Zarour, Hassane M.
|
|
|
34 |
S3 |
p. S1357
|
artikel
|
| 406 |
SY22-5 Toward precision medicine in lymphoma: Challenges and opportunities
|
Nakamura, Hirotaka
|
|
|
34 |
S3 |
p. S1369
|
artikel
|
| 407 |
SY06-2 Treatment and survivorship for premenopausal women with breast cancer
|
Ono, Makiko
|
|
|
34 |
S3 |
p. S1359
|
artikel
|
| 408 |
Table of Contents
|
|
|
|
34 |
S3 |
p. v
|
artikel
|
| 409 |
Title Page
|
|
|
|
34 |
S3 |
p. iv
|
artikel
|
Tijdschrift beschrijving